According to a commentary, the potential value of a large-scale switch to a diet rich in ω-3 fatty acids merits serious attention. It notes diet modification is a cornerstone of diabetes care, so there should be plenty of opportunity to run randomised trials of various alternatives with preplanned ocular end points.